RxDoctor Payments Data

Valorie Cook

Psychiatric/Mental Health · Caro, MINPI 1942801204

Payments from drug & device makers

$2,911in general payments, 2019–2025

Across 137 payments — averaging $21.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lundbeck LLC$702
  • Neurocrine Biosciences, Inc.$376
  • AbbVie$343
  • Alkermes, Inc.$334
  • Otsuka America Pharmaceutical, Inc.$242
  • Teva Pharmaceuticals USA, Inc.$213
  • plus $701 from 9 others

What the payments were for

  • Food & beverage$2,79996%
  • Education$1114%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,911 in reported general payments places this provider in the 80th percentile of 638 psychiatric/mental health providers in Michigan.

See all psychiatric/mental health providers in Michigan

Medicare billing

Part B allowed, 2024
$16,638
Medicare patients
64
Services billed
222

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl82$110,877
RexultiBrexpiprazole19$24,065
Quetiapine Fumarate ErQuetiapine Fumarate21$6,651
Buspirone Hcl331$3,837
Lurasidone Hcl18$3,613
Ziprasidone Hcl55$2,877
Oxcarbazepine143$2,756
Divalproex Sodium56$2,646
Quetiapine Fumarate318$2,521
Trazodone Hcl222$2,304
Venlafaxine Hcl ErVenlafaxine Hcl73$2,273
Duloxetine Hcl129$2,186
Lamotrigine225$2,179
Lamotrigine ErLamotrigine18$2,023
Doxepin Hcl36$1,747

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$343$110,87782 claims
Otsuka America Pharmaceutical, Inc.Rexulti$242$24,06519 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 638 psychiatric/mental health providers in Michigan.

Other psychiatric/mental health in Caro

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →